These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13077745)

  • 21. [Retardation of elimination of paraminosalicylic acid by benemid].
    WILHELMI E; SANZ MC
    Schweiz Z Tuberk; 1952; 9(4):296-305. PubMed ID: 14958399
    [No Abstract]   [Full Text] [Related]  

  • 22. Tolerance of phenyl para-aminosalicylate, a comparative study.
    COHEN SS; YUE WY; TSAI SH
    Dis Chest; 1962 Oct; 42():379-83. PubMed ID: 14022105
    [No Abstract]   [Full Text] [Related]  

  • 23. PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases.
    Acta Tuberc Scand; 1952; 27(3-5):157-75. PubMed ID: 13040105
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombocytopenia induced by administration of sodium para-aminosalicylate.
    GREGG JA; MAYOCK RL
    J Am Med Assoc; 1960 Apr; 172():1909-12. PubMed ID: 13851676
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment in pulmonary tuberculosis with subcutaneous (Para-Aminosalicylic Acid) PAS infusisons].
    Berger G; Kirschner H
    Tuberkulosearzt; 1956 Mar; 10(3):154-60. PubMed ID: 13324973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Perfusions with solutions of para-aminosalicylic acid (PAS) in the treatment of pulmonary tuberculosis].
    PARAF J; ZIVY P; DESBORDES J; BORY I; PARAF
    Bull Acad Natl Med; 1951 Nov-Dec 4; 135(35-36):622-4. PubMed ID: 14925494
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of P-(di-n-propylsulfamyl)-benzoic acid (benemid) to influence p-aminosalicylic acid blood levels.
    RILEY C; CLOWATER RA; SHANE SJ
    Dis Chest; 1953 Jan; 23(1):90-3. PubMed ID: 12998452
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of benemid in the administration of para-aminosalicylic acid].
    DE FOCKERT JA
    Ned Tijdschr Geneeskd; 1957 Jan; 101(2):112-4. PubMed ID: 13418829
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of the PAS salt of isoniazid in pulmonary tuberculosis].
    KOURILSKY R; KOURILSKY S; THUILLIER Y
    Sem Hop; 1956 Jun; 32(34):1948-55. PubMed ID: 13351700
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxic psychiatric manifestations in the treatment of tuberculosis with sodium para-aminosalicylate.
    PUGH DL; EDWORDS GS; MCLAREN RG; JONES ER
    Tubercle; 1952 Dec; 33(12):369-76. PubMed ID: 13005721
    [No Abstract]   [Full Text] [Related]  

  • 32. Dramamine (dimenhydrinate) as an adjunct to PAS (para-aminosalicylic acid) in the treatment of pulmonary tuberculosis.
    LEONARD LI
    Dis Chest; 1953 Dec; 24(6):601-7. PubMed ID: 13107557
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired hypersensitivity to sodium PAS and streptomycin.
    ROWLANDS SD
    Tubercle; 1953 May; 34(5):143-4. PubMed ID: 13056998
    [No Abstract]   [Full Text] [Related]  

  • 34. Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration.
    DIFS H
    Acta Tuberc Scand; 1951; 25(2-3):128-63. PubMed ID: 14810565
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical observations on viomycin sulphate in the treatment of tuberculosis.
    HACKNEY RL; KING EQ; MARSHALL EE; HARDEN KA; PAYNE HM
    Dis Chest; 1953 Dec; 24(6):591-600. PubMed ID: 13107556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Potassium p-aminosalicylate in the treatment of pulmonary tuberculosis].
    REBORA F; VALENCIA H
    Gac Med Mex; 1959 Oct; 89():841-50. PubMed ID: 14436749
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined hypersensitivity reaction to sodium para-aminosalicylate and associated antibacterial drug concurrently administered.
    COHEN AA; LAWRENCE SH
    Ann Intern Med; 1957 May; 46(5):893-906. PubMed ID: 13411899
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypokalaemia complicating sodium para-amino-salicylate therapy for pulmonary tuberculosis.
    HEARD KH; CAMPBELL AH; HURLEY JJ; FERGUSON E
    Med J Aust; 1950 Oct; 2(17):606-12. PubMed ID: 14785411
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibiotics (streptomycin and PAS) in the treatment of pulmonary tuberculosis].
    GILBERT M
    Med Hyg (Geneve); 1950 Nov; 8(182bis):422. PubMed ID: 14795997
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rôle of para-aminosalicylic acid in pulmonary tuberculosis therapy].
    CHRETIEN J
    Gaz Med Fr; 1951 Mar; 58(5):317-24. PubMed ID: 14823253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.